Curative Biotechnology (CUBT) News Today

$0.03
0.00 (0.00%)
(As of 04/23/2024 ET)
SourceHeadline
globenewswire.com logoCurative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
globenewswire.com - March 31 at 7:00 PM
seekingalpha.com logoSFRX Seafarer Exploration Corp.
seekingalpha.com - March 29 at 11:17 AM
globenewswire.com logoCurative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
globenewswire.com - March 22 at 9:45 AM
insidermonkey.com logoShould You Expect Strong Financial Growth For Legend Biotech Corporation (LEGN)?
insidermonkey.com - January 22 at 8:50 AM
finanznachrichten.de logoCurative Biotechnology, Inc.?: Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
finanznachrichten.de - October 31 at 3:39 PM
thestreet.com logo3 Best Biotech Stocks to Add to Your Portfolio
thestreet.com - August 18 at 2:33 AM
finance.yahoo.com logoCurative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions
finance.yahoo.com - June 6 at 11:43 AM
bizjournals.com logoSacramento Biotech News
bizjournals.com - June 2 at 6:40 PM
finance.yahoo.com logoCurative Biotechnology, Inc. Files Patent on Ophthalmic Formulation
finance.yahoo.com - May 24 at 10:41 AM
finanznachrichten.de logoCurative Biotechnology, Inc.?: Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study
finanznachrichten.de - January 5 at 10:14 AM
finance.yahoo.com logoCurative Biotechnology, Inc. (CUBT)
finance.yahoo.com - November 12 at 6:15 PM
seekingalpha.com logoCurative Biotechnology refiles for NYSE uplisting, $8M offering
seekingalpha.com - November 8 at 11:24 AM
finanznachrichten.de logoCurative Biotechnology, Inc.: Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange
finanznachrichten.de - October 20 at 5:04 AM
seekingalpha.com logoCurative Biotechnology files for NYSE American uplisting, $8M IPO
seekingalpha.com - September 30 at 8:46 PM
benzinga.com logoCurative Biotechnology Stock (OTC:CUBT), Short Interest Report
benzinga.com - September 26 at 4:07 PM
seekingalpha.com logoCUBT Curative Biotechnology, Inc.
seekingalpha.com - September 22 at 2:42 PM
finance.yahoo.com logoCurative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors
finance.yahoo.com - June 16 at 11:05 AM
finance.yahoo.com logoCurative Biotechnology, Inc. Names Cary Sucoff to Board of Directors
finance.yahoo.com - May 12 at 3:44 PM
finance.yahoo.com logoCurative Biotechnology, Inc. Appoints Cary Sucoff to Board of Directors
finance.yahoo.com - May 12 at 10:44 AM
yahoo.com logoCan You Pay a Mortgage With a Credit Card?
yahoo.com - May 4 at 8:43 PM
finance.yahoo.com logoCurative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration
finance.yahoo.com - May 3 at 1:48 PM
finance.yahoo.com logoCurative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration
finance.yahoo.com - May 3 at 1:48 PM
seekingalpha.com logoCurative signs agreement with NEI to develop age-related eye disease treatment
seekingalpha.com - March 21 at 1:24 PM
morningstar.com logoEmily Y. Chew, M.D. of the National Eye Institute Assigned Principal Investigator
morningstar.com - March 21 at 1:24 PM
finance.yahoo.com logoCurative Biotechnology Announces Cooperative Research and Development Agreement(CRADA) with the National Eye Institute (NEI) for Clinical Evaluation of its Proprietary Ocular Metformin Formulation in Age-Related Macular Degeneration
finance.yahoo.com - March 21 at 1:24 PM
finance.yahoo.com logo[UPDATED] CURATIVE BIOTECHNOLOGY ANNOUNCES OCULAR TOLERANCE EVALUATION OF METFORMIN EYE DROP FORMULATIONS FOR TREATMENT OF MACULAR DEGENERATION
finance.yahoo.com - November 24 at 3:29 PM
finance.yahoo.com logoCURATIVE BIOTECHNOLOGY ANNOUNCES OCULAR TOLERANCE EVALUATION OF METFORMIN EYE DROP FORMULATIONS FOR TREATMENT OF MACULAR DEGENERATION
finance.yahoo.com - November 24 at 10:28 AM
finance.yahoo.com logoCURATIVE BIOTECHNOLOGY ANNOUNCES DR. CATHERINE SOHN AS SPECIAL ADVISOR TO BOARD AND CEO
finance.yahoo.com - October 12 at 12:33 PM
apnews.com logoCURATIVE BIOTECHNOLOGY ANNOUNCES IMT504 LICENSE FOR DEVELOPMENT OF PROPRIETARY NEXT-GEN ...
apnews.com - October 8 at 10:26 AM
prnewswire.com logoCurative Biotechnology Announces IMT504 License For Development Of Proprietary Next-Gen COVID-19 Vaccine
prnewswire.com - October 7 at 1:18 PM
finance.yahoo.com logoCURATIVE BIOTECHNOLOGY ANNOUNCES IMT504 LICENSE FOR DEVELOPMENT OF PROPRIETARY NEXT-GEN COVID-19 VACCINE
finance.yahoo.com - October 7 at 1:18 PM
apnews.com logoCurative Biotechnology, Inc. Announces Addition of Dr. Nicholas Boulis to Scientific and ...
apnews.com - September 3 at 6:52 AM
Get Curative Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CUBT and its competitors with MarketBeat's FREE daily newsletter.

Exposed: 10 CENT Crypto to Explode April 20th? (Ad)

Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin

Click For My #1 FREE Crypto for 2024

CUBT Media Mentions By Week

CUBT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CUBT
News Sentiment

0.00

0.46

Average
Medical
News Sentiment

CUBT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CUBT Articles
This Week

0

0

CUBT Articles
Average Week

Get Curative Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CUBT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:CUBT) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners